Health in Germany

1,089 indicators covering health for Germany.

IndicatorLatest Year10-yr change Rank
Pharmacists 6.65 2023 up 4.7% 57th
Low birth weight prevalence 6.7% 2020 down 2.9% 124th
Inactivated first-dose polio vaccine (IPV1) immunization coverage amon 97.0% 2025 down 1.0% 60th
Low birth weight number 51.1 2020 up 10.4% 40th
Number of new hivaids infections who 2,200 2024 down 8.3% 54th
Reported rabies deaths 0 2023 β€” 61st
Number of current cigarette smokers, estimate 9.00 million 2030 down 25.1% 17th
Concentrations of fine particulate matter 9.43 2023 down 31.1% 151st
Death rate road traffic injuries 3.8 2019 down 20.8% 169th
New or unknown treatment history cases: Pulmonary, bacteriologically c 2,584 2022 up 21.2% 80th
Cholera case fatality rate 0 2014 β€” 37th
Life satisfaction vs life expectancy 81.38 2023 up 1.1% 45th
Estimate of current cigarette smoking prevalence 12.7% 2030 down 24.4% 81st
Estimate of current cigarette smoking prevalence (%) 14.9% 2030 down 20.7% 68th
Number of children aged 6-59 months with anaemia 601.87 2019 up 50.0% 63rd
Prevalence of anaemia in children aged 6-59 months 15.1% 2019 up 28.0% 164th
Number of deaths attributed to non-communicable diseases, by type of d 228,811 2019 up 4.3% 7th
Hepatitis B surface antigen (HBsAg) prevalence 0.0% 2024 β€” 132nd
Mean hemoglobin level of children aged 6-59 months 121 2019 down 0.8% 12th
Estimated number of MDR/RR-TB incident cases 150 2024 down 11.8% 84th
Mortality caused by road traffic injury 3.8 per 100,000 population 2019 down 28.3% 170th
Mortality caused by road traffic injury, female 1.9 per 100,000 female population 2019 down 32.1% 166th
Mortality caused by road traffic injury, male 5.7 per 100,000 male population 2019 down 28.8% 168th
Ipv vaccine coverage 97 2024 down 1.0% 52nd
Hospital beds 75.5 2023 down 8.3% 8th
Treatment success rate for patients treated for MDR-TB 45.0% 2022 down 4.3% 147th
New leprosy case detection rate per 1 000 000 population 0.012 2024 down 52.0% 123rd
Peri-neonatal mortality by age of mother and parity, by NUTS 2 region 2,216 2023 down 9.5% 4th
Fetal, peri- and neonatal mortality rates by NUTS 2 region of 1.45 2023 down 59.9% 30th
Bladder cancer death rate 2.26 2020 down 13.5% 42nd
Cancer death rates by type who db 2.26 2020 down 13.5% 42nd
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) i 88.0% 2025 β€” 89th
International Health Regulations core capacity scores, SPAR version, 2 90 2025 β€” 14th
Leprosy registered prevalence rate per 1 000 000 population 0.012 2024 β€” 120th
Leprosy - Number of new leprosy cases among children 0 2024 β€” 69th
Leprosy - Number of cases registered for treatment 1 2024 β€” 113th
New leprosy child case detection rate (less than 15 years of age) per 0 2024 β€” 69th
Hospital discharges by diagnosis and NUTS 2 region, day cases, total 417,605 2021 down 23.0% 11th
Hospital discharges by diagnosis and NUTS 2 region, day cases, total 207,277 2021 down 20.4% 11th
Hospital discharges by diagnosis and NUTS 2 region, day cases, total 210,328 2021 down 25.4% 11th
Hospital days of in-patients by NUTS 2 region - females - historical 82.46 million 2021 down 16.1% 1st
Ipv1 number unvaccinated 23,227 2023 up 61.0% 72nd
Hospital days of in-patients by NUTS 2 region - males - historical 76.26 million 2021 down 12.2% 1st
Hospital days of in-patients by NUTS 2 region - total - historical 158.72 million 2021 down 14.3% 1st
Hospital discharges by diagnosis and NUTS 2 region, in-patients 18.13 million 2021 down 8.8% 1st
Hospital discharges by diagnosis, NUTS 2 region, in-patients and 9.47 million 2021 down 10.0% 1st
Hospital discharges by diagnosis and NUTS 2 region, in-patients 8.66 million 2021 down 7.4% 1st
Contraceptive prevalence, any method 80.3% 2011 up 17.4% 6th
Hospital discharges by diagnosis and NUTS 2 region, day cases, per 502 2021 down 24.3% 20th
Hospital discharges by diagnosis and NUTS 2 region, day cases, per 491.8 2021 down 21.4% 20th
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Hospital discharges by diagnosis and NUTS 2 region, day cases, per 512.4 2021 down 27.0% 19th
Liver cancer death rate 4.07 2020 down 0.1% 60th
Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 21,790 2021 down 10.3% 3rd
Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 22,470 2021 down 11.0% 3rd
Hospital discharges by diagnosis and NUTS 2 region, in-patients, per 21,092 2021 down 9.4% 3rd
Number of female leprosy new cases 0 2024 β€” 102nd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 β€” 157th
Contraceptive prevalence, any modern method 80.2% 2011 up 24.3% 3rd
Number of prevalent tuberculosis cases 6,300 2014 down 28.4% 94th